AMALGAMATED BANK - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 213 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMALGAMATED BANK ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$778
-21.7%
16,922
-2.1%
0.01%
-12.5%
Q2 2023$993
+53.7%
17,279
+0.3%
0.01%
+33.3%
Q1 2023$646
+25.2%
17,221
-6.5%
0.01%
+20.0%
Q4 2022$516
-99.9%
18,409
-0.9%
0.01%0.0%
Q3 2022$522,000
-17.5%
18,577
+2.0%
0.01%
-16.7%
Q2 2022$633,000
+4.3%
18,206
+7.7%
0.01%
+20.0%
Q1 2022$607,000
-27.4%
16,909
-52.9%
0.01%
+66.7%
Q4 2021$836,000
+148.1%
35,866
+102.4%
0.00%0.0%
Q3 2021$337,000
-7.2%
17,720
-1.6%
0.00%0.0%
Q2 2021$363,00018,0110.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
LAM GROUP, INC. 128,000$5,886,7205.78%
Beacon Harbor Wealth Advisors, Inc. 103,095$4,7411.58%
Capital Impact Advisors, LLC 15,304$703,8311.18%
Quantedge Capital Pte Ltd 36,389$1,673,5300.91%
Mesirow Institutional Investment Management, Inc. 183,805$8,453,1920.86%
Monashee Investment Management LLC 39,461$1,814,8110.76%
OBERWEIS ASSET MANAGEMENT INC/ 152,500$7,013,4750.74%
Granite Investment Partners, LLC 330,911$15,218,5970.64%
Portolan Capital Management 132,850$6,109,7720.57%
SHAKER INVESTMENTS LLC/OH 20,795$956,3620.53%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders